XERS Xeris Biopharma Holdings, Inc.
Price Chart
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Xeris Biopharma Holdings, Inc. (XERS) includes Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), suggesting a possible investor presentation or public disclosure of material information, but no specific details or financial data are accessible to confirm content or implications.
Actionable Insight
Monitor for the release of the missing exhibit (EX-99.1) which may contain an investor presentation or preliminary financial results. Absent content, no trading decision should be made based on this filing alone.
Key Facts
- Filing is an 8-K for Xeris Biopharma Holdings, Inc. (XERS)
- Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
- No document content available to verify disclosures, financials, or strategic updates
- Exhibit 99.1 (press release or presentation) was likely filed but not accessible
Financial Impact
Not specified
Risk Factors
- Material information may have been disclosed that is not reflected in this analysis
- Potential for market-moving guidance or results being missed due to document unavailability
Market Snapshot
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
3d ago
|
Institutional Cluster
| $6.93 awaiting T+1 | awaiting T+1 | — | $6.79 (−2.02%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 4, 2026
10d ago
|
144
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 3, 2026
11d ago
|
144
| $6.15 $6.18 | ▲ +0.49% | ▲ +3.06% | $6.79 (+10.41%) |
|
Feb 27, 2026
15w ago
|
8-K
| $6.12 $6.02 | ▼ −1.63% | ▼ −1.69% | $6.79 (+10.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access